Target
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Ligand
BDBM133675
Substrate
n/a
Meas. Tech.
Fluorescence Based Assay
pH
6.5±n/a
Temperature
298.15±n/a K
IC50
170±n/a nM
Comments
extracted
Citation
 Gerusz, VEscaich, SOxoby, MDenis, A Heterocyclic acrylamides and their use as pharmaceuticals US Patent  US9051321 Publication Date 6/9/2015 
Target
Name:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI
Synonyms:
Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | Enoyl-acyl carrier protein reductase (FaBI) | FABI_STAA8 | NADPH-dependent enoyl-ACP reductase (FabI) | fabI
Type:
Enzyme
Mol. Mass.:
28019.03
Organism:
Staphylococcus aureus
Description:
Q2FZQ3
Residue:
256
Sequence:
MLNLENKTYVIMGIANKRSIAFGVAKVLDQLGAKLVFTYRKERSRKELEKLLEQLNQPEAHLYQIDVQSDEEVINGFEQIGKDVGNIDGVYHSIAFANMEDLRGRFSETSREGFLLAQDISSYSLTIVAHEAKKLMPEGGSIVATTYLGGEFAVQNYNVMGVAKASLEANVKYLALDLGPDNIRVNAISASPIRTLSAKGVGGFNTILKEIEERAPLKRNVDQVEVGKTAAYLLSDLSSGVTGENIHVDSGFHAIK
  
Inhibitor
Name:
BDBM133675
Synonyms:
US8846711, 19 | US9051321, 19
Type:
Small organic molecule
Emp. Form.:
C18H21N3O3
Mol. Mass.:
327.3776
SMILES:
CC(=C)COC1CN(C1)C(=O)\C=C\c1cnc2NC(=O)CCc2c1
Structure:
Search PDB for entries with ligand similarity: